Exam (elaborations)
Lisa Gorski, Phillips' Man of IV Therapeutics 8th edition
- Course
- Institution
- Book
Lisa Gorski, Phillips' Man of IV Therapeutics 8th edition
[Show more]
Connected book
Book Title:
Author(s):
- Edition:
- ISBN:
- Edition:
More summaries for
-
TEST BANK FOR PHILLIPS’S MANUAL OF I.V. THERA- PEUTICS: EVIDENCE-BASED PRACTICE FOR INFUSION THERAPY 7TH EDITION LISA GORSKI ISBN
-
Lisa Gorski, Phillips' Man of IV Therapeutics 8th edition
-
Lisa Gorski, Phillips' Man of IV Therapeutics 8th edition
Seller
Follow
kushboopatel6867
Content preview
TEST BANK for Lisa Gorski, Phillips' Man of IVTherapeutics 8th edition
Which of the following steps are not parts of the multistage process of
carcinogenesis?
A. initiation
B. promotion
C. propagation
D. transformation - ANSWER:C
A new genetic alteration is identified in an individual patient's resected tumor. The
normal gene product appears to inhibit inappropriate cellular growth and
proliferation. Which of the following terms adequately classifies the gene?
A. proto-angiogenic gene
B. oncogene
C. tumor suppressor gene
D. DNA repair gene - ANSWER:C
A 65-year-old man is recently diagnosed with locally advanced colon cancer. The
cancer has spread to regional lymph nodes, but not distant sites. The patient
undergoes major surgery to remove the tumor. Following surgery, the patient will
receive combination chemotherapy. Which of the following best describes the
treatment?
A. adjuvant
B. curative
C. induction
D. palliative - ANSWER:A
The patient will receive oxaliplatin, fluorouracil, and leucovorin. Leucovorin is
included in the chemotherapy regimen to:
A. reduce fluorouracil toxicity
B. increase fluorouracil cytotoxicity
C. reduce oxaliplatin toxicity
D. increase oxaliplatin cytotoxicity - ANSWER:B
Which of the following toxicities is not usually associated with the EGFR inhibitor
class of anticancer agents?
A. rash
B. myelosuppression
C. hepatotoxicity
D. diarrhea - ANSWER:B
,Based on the name, what is the source of the monoclonal antibody trastuzumab?
A. murine
B. human
C. chimeric
D. humanized - ANSWER:D
Which of the following are considered risk factors for developing breast cancer?
A. Age, late menarche, early menopause.
B. Hormone replacement therapy, early menarche, early menopause.
C. Age, hormone replacement therapy, first pregnancy after age 30.
D. Hormone replacement therapy, first pregnancy after age 30, early menopause.
E. Age, first pregnancy after age 30, early menopause. - ANSWER:C
Multiple myeloma (MM) is a malignancy characterized by the overproduction of
which cell type?
A. Myeloid stem cells
B. Neutrophils
C. Plasma cells
D. Platelets - ANSWER:C
Parkinson disease (PD) is characterized by a nigrostriatal deficiency of:
A. Acetylcholine
B. Dopamine
C. Norepinephrine
D. Serotonin - ANSWER:B
The clinical diagnosis of parkinsonism is based on the presence of bradykinesia and
at least one of three other features: muscular rigidity, resting tremor, and:
A. Dystonia
B. Nystagmus
C. Postural instability
D. Seizures - ANSWER:C
Which of the following is the most effective drug for PD?
A. Amantadine
B. Carbidopa/levodopa
C. Pramipexole
D. Rasagiline - ANSWER:B
An 80-year-old with newly diagnosed PD and a history of memory problems and
confusion is best treated with:
, A. Amantadine
B. Carbidopa/levodopa
C. Trihexyphenidyl
D. Ropinirole - ANSWER:B
The mechanism of action for entacapone is:
A. COMT inhibition
B. MAO-B inhibition
C. D2-receptor inhibition
D. Dopa-decarboxylase inhibition - ANSWER:A
Which of the following will not worsen PD symptoms?
A. Haloperidol
B. Metoclopramide
C. Prochlorperazine
D. Rasagiline - ANSWER:D
A patient with PD is taking carbidopa/levodopa 25/100 mg three times a day, and
reports that he tends to slow down 2 hours before his next carbidopa/levodopa
dose. This patient is most likely experiencing:
A. Delayed onset response
B. Dyskinesia
C. Freezing
D. Wearing off - ANSWER:D
A 70-year-old patient taking carbidopa/levodopa 25/100 mg three times a day for PD
is experiencing end-of-dose wearing off. The best next step is to:
A. Add tolcapone.
B. Consider surgery.
C. Add trihexyphenidyl.
D. Increase carbidopa/levodopa to four times daily - ANSWER:D
A 63-year-old patient taking carbidopa/levodopa 25/100 mg four times a day for PD
is experiencing end-of-dose wearing off. The best recommendation is to:
A. Add tolcapone.
B. Add entacapone.
C. Consider deep-brain stimulation (DBS).
D. Change carbidopa/levodopa to three times a day. - ANSWER:B
A 72-year-old patient with moderate-severe PD was placed on carbidopa/levodopa
25/100 mg three times a day by his primary care physician. He is complaining of
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller kushboopatel6867. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $17.99. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
73314 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now